Global API Contract Manufacturing Market Growth (Status and Outlook) 2023-2029

Global API Contract Manufacturing Market Growth (Status and Outlook) 2023-2029

Contract manufacturing is the process where manufacturer engages into an agreement with the companies for component or product manufacturing. Active pharmaceutical ingredient (API) contract manufacturing refers to the development of pharmaceutical drugs through contract manufacturing by outsourcing to other companies.

LPI (LP Information)' newest research report, the “API Contract Manufacturing Industry Forecast” looks at past sales and reviews total world API Contract Manufacturing sales in 2022, providing a comprehensive analysis by region and market sector of projected API Contract Manufacturing sales for 2023 through 2029. With API Contract Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world API Contract Manufacturing industry.

This Insight Report provides a comprehensive analysis of the global API Contract Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on API Contract Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global API Contract Manufacturing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for API Contract Manufacturing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global API Contract Manufacturing.

The global API Contract Manufacturing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for API Contract Manufacturing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for API Contract Manufacturing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for API Contract Manufacturing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key API Contract Manufacturing players cover AstraZeneca Plc, BoehringerIngelhein GmbH, GlaxoSmithKline Pharmaceuticals Ltd, Merck＆Co.，Inc, Novartis AG, Piramal Pharma Solutions, Ranbaxy Laboratories Ltd., Reddy's Laboratories Ltd and Sandoz-Lek-Biochemie, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of API Contract Manufacturing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Commercial Manufacturing
Clinical Manufacturing

Segmentation by application
Oncology
Central nervous system
Cardiovascular disorder
Infectious diseases
Pulmonary disorders
Metabolic disorder
Gastrointestinal disorders
Musculoskeletal disorders
Genitourinary disorders

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AstraZeneca Plc
BoehringerIngelhein GmbH
GlaxoSmithKline Pharmaceuticals Ltd
Merck＆Co.，Inc
Novartis AG
Piramal Pharma Solutions
Ranbaxy Laboratories Ltd.
Reddy's Laboratories Ltd
Sandoz-Lek-Biochemie
Sun Pharmaceutical Industries Ltd
Teva Pharmaceuticals Industries Ltd

Please note: The report will take approximately 2 business days to prepare and deliver.